MedTrace Logo

Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression

NCT00532103 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2008-09-22

No results posted yet for this study

Summary

This study will develop a new methodology to evaluate any treatment-emergent suicidal ideation that might occur when an antidepressant treatment has been started and/or during times when doses are increased in patients with major depressive disorder.

Conditions

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    lead NIH

Principal Investigators

  • Madhukar Trivedi, MD · University of Texas Southwestern Medical Center

  • Stephen R. Wisniewski, PhD · University of Pittsburgh

  • Diane Warden, PhD, MBA · University of Texas Southwestern Medical Center

  • Kathy Shores-Wilson, PhD · University of Texas Southwestern Medical Center

  • David W. Morris, PhD · University of Texas Southwestern Medical Center

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00532103 on ClinicalTrials.gov